Demand for flying is steadily increasing amid declining fear about the novel coronavirus. That bodes well for Delta (NYSE:DAL) stock. Source: NextNewMedia / Shutterstock.com Delta’s cash burn has tremendously decreased and is quite manageable. Also, the recent spike in coronavirus cases in a few locations is not going to result in the type of all-encompassing
Stocks to buy
It’s not the most famous cloud-based tech firm on the planet, but Fastly (NYSE:FSLY) is a name that’s gaining traction lately. The buzz surrounding FSLY stock is well-earned as this company is far from a cloud-computing Johnny-come-lately. Source: Shutterstock Commentators shouldn’t throw the word “innovator” around lightly. However, the term is entirely appropriate in the
Moderna (NASDAQ:MRNA) is one of those stocks you trade on news because fundamentals don’t exist. MRNA stock, which only came public late last year, has a market capitalization of $22 billion after racking up sales of $60 million for all of 2019. Source: Shutterstock When it came public I recommended readers buy it. Those who
At first, Qualcomm (NASDAQ:QCOM) stock fell off a cliff in response to the Covid-19 pandemic, with shares dropping from $90 in late February to $58 in late March. Then, QCOM stock sharply reversed course and rallied all the way back to $90 on optimism that the pandemic will inflict only temporary and minor damage on
Editor’s note: This article is part of InvestorPlace.com’s Best Stocks for 2020 contest. Matt McCall’s pick for the contest is Aimmune Therapeutics (NASDAQ:AIMT). Six months ago, I introduced you to Aimmune Therapeutics (NASDAQ:AIMT) as my pick in the Best Stocks for 2020 contest. It’s a leading biopharmaceutical that focuses specifically on the unmet needs of people who suffer
Lululemon (NASDAQ:LULU) has been lagging since the company reported earnings in early June. However, LULU stock caught a bid on June 30, on news that it will acquire Mirror for $500 million. Source: Sorbis / Shutterstock.com Shares closed off the highs, but still climbed 6% on the day. Why the enthusiasm? Because Lululemon bought into a
At the beginning of the week, DocuSign (NASDAQ:DOCU) stock saw its share price decline. Investors looked at economic reopening across the U.S. as a negative for the firm’s future performance. DocuSign specializes in orchestrating contracts online and is best-known for its eSignature service, which allows people to sign contracts electronically. Source: Sundry Photography / Shutterstock.com When
Editor’s note: This article is part of InvestorPlace.com’s Best Stocks for 2020 contest. Eric Fry’s pick for the contest is Freeport-McMoRan (NYSE:FCX). When we last discussed Freeport-McMoRan (NYSE:FCX), the novel coronavirus pandemic was in full force, the U.S. stock market was struggling to recover from a wicked 34% drop and copper prices had tumbled to a three-year low. This
If you can ignore the humidity and 90-degree temperatures, you can almost convince yourself it’s March and not July. Spring training baseball is restarting and professional basketball and hockey playoffs are around the corner. If you hold Penn National Gaming (NASDAQ:PENN) stock, these are all good signs. Source: Casimiro PT / Shutterstock.com The novel coronavirus
The Institute for Supply Management supplies a monthly look at the U.S. manufacturing market. In April, that index hit an 11-year low. But since then, the numbers have been rising. They’re not going wild, but they’re rising. You have seen this in the housing market where new home purchases are growing — mortgage demand is
I’ve been recommending Square (NYSE:SQ) for this entire year. Admittedly, at first that call looked a bit shaky. The novel coronavirus pandemic sent stocks plunging — and Square stock wasn’t immune. Source: IgorGolovniov / Shutterstock.com The company’s exposure to small businesses suggested significant risk if the broader economy went into a tailspin. At the lows,
Editor’s note: This column is part of InvestorPlace.com’s Best Stocks for 2020 contest. Jason Moser’s pick for the contest is Wayfair (NYSE:W). To say that 2020 has been a crazy year for the stock market would be putting it mildly. And what about for my InvestorPlace.com Best Stocks pick? To say that 2020 has been a crazy year for shareholders
Editor’s note: This article is a part of InvestorPlace.com’s Best Stocks for 2020 contest. The Readers’ Choice pick for the contest is Apple (NASDAQ:AAPL). Despite all the chaos in the stock market this quarter, investors have been able to count on a few certainties. You’re likely reading this on an iPhone or a Mac, perhaps an iPad. And if
The novel coronavirus has accelerated a digital shift in just about every industry. Working from home, homeschooling, e-commerce, and telemedicine are just a few ways coronavirus has upended the way people interact. But with all of that online exposure comes a greater risk of data breaches, which is why many investors have started to look
The coronavirus outbreak has caused a lot of negative impact on consumer demand, unemployment and stocks in industries like travel and leisure took a big hit. During this pandemic, consumers changed their preferences and way of living in a way nobody would have imagined before. Shares of Zoom (NASDAQ:ZM) performed very well during this pandemic.
Medical device maker Hologic (NASDAQ:HOLX) has carved out a meaningful place in the field of women’s health. But it’s the company’s tests for the novel coronavirus that are fueling the present upward trend, making Hologic stock an appealing growth stock as we head into the second half of the year. Source: Cryptographer / Shutterstock.com Since
With a coronavirus vaccine looking more likely and the sales of electric cars poised to accelerate, General Electric (NYSE:GE) shares seem very attractive. Moreover, the company’s new offshore wind turbine should generate tremendous value for long-term investors in GE stock. Source: JPstock / Shutterstock.com The chances of a viable coronavirus vaccine emerging within the next
It’s expected that between 2019 and 2027, the global marijuana industry will grow at a compound annual growth rate of 18.1%. By 2027, the market is expected to be worth $73.6 billion. Given the big potential for growth, marijuana stocks have been in focus. However, marijuana stocks have been on a decline since March 2019,
Investing in marijuana stocks has been anything but smooth lately. The cannabis industry was no more immune to the novel coronavirus than the rest of the wider markets. However, that doesn’t mean it’s time to abandon pot stocks altogether. The story of 2020 is still unfinished, and there’s comeback potential for a number of stocks
The novel coronavirus pandemic has swept away several industries but has been a bit of a blessing for the biotech sector. iBio (NYSEMKT:IBIO) is one company that is benefiting from the hype surrounding the push for a vaccine, as iBio stock gained 490% this year. Source: Shutterstock As I discussed in my previous article, iBio’s